Among the genes upregulated in the model group compared to the control group and the genes downregulated in the treatment group compared to the model group, there were 11 genes in common through Venn diagram analysis (Fig 1A). These 11 common genes are shown in Table 1 and Table 2.
According to Table 1, a heatmap was drawn, as shown in Fig 1B. There are 3 genes that clustered well, namely, ENSTBEG00000013408, ENSTBEG00000006837 and ENSTBEG00000006937. These 3 genes were significantly elevated in the model group. Compared with the normal group, these three genes may be gene markers that are significantly elevated in the model group.
According to Table 2, a heatmap was drawn, as shown in Fig 2A. There are 5 genes that clustered well, namely, ENSTBEG00000009022, ENSTBEG00000013408, ENSTB EG00000017424, ENSTBEG00000006837 and ENSTBEG 00000003426. The expression levels of these 5 genes were significantly reduced after treatment. Compared with the model group, they may be the gene markers of reduction in the treatment group.
Among the genes downregulated in the model group and the control group and the genes upregulated compared with the treatment group and the model group, there were 11 shared genes identified through Venn diagram analysis (Fig 2B). These 11 shared genes are shown in Table 3 and Table 4.
According to Table 3, a heatmap was drawn, as shown in Fig 2C. There is one gene with better clustering/: ENSTBEG00000021330. This gene was significantly decreased in the model group. Compared with the normal group, this gene may be a gene marker that was significantly decreased in the model group.
According to Table 4, a heatmap was drawn as shown in Fig 2D. There is one gene with better clustering: ENSTBEG00000021330. This gene was significantly increased in the treatment group. Compared with the model group, it may be a meaningful gene marker for recovery after treatment.
KEGG results compared with the model group and the control group
3Compared with the control group, the KEGG pathway analysis results of downregulated differentially expressed genes (Fig 3A) were as follows:
Compared with the model group and the control group, the upregulated differentially expressed genes were subjected to KEGG pathway analysis (Fig 3B).
KEGG results of the comparison of the treatment and control groups
Compared with the control group, the KEGG pathway analysis results of downregulated differentially expressed genes (Fig 4A) were as follows.
KEGG pathway analysis of the upregulated differentially expressed genes compared with the control group (Fig 4B)
KEGG results in comparison of treatment and model groups
Compared with the treatment group and the model group, the KEGG pathway analysis results of down-regulated differentially expressed genes (Fig 5A) were as follows.
KEGG pathway analysis of the upregulated differentially expressed genes compared with the model group (Fig 5B).
Trend analysis results
Using the intersection of all differential genes in the normal group compared to the model group and the intersection of all the differentially expressed genes in the treatment group compared with the model group, a total of 35 genes were obtained. Trend analysis of these 35 genes was carried out and the results are as follows. The red box is a significant difference between the model group and the normal group and the treatment group. There were 11 genes in total. The blue box is the significant difference between the model group and the normal group and the treatment group, with a total of 7 genes. The lower figure (Fig 6) is the corresponding trend analysis result.
In modern local wars, all kinds of explosive weapons have high explosive power, many shrapels that can be projected in a fan shape or three-dimensional, large killing area and accurate targeting ability
(Li et al., 2018). The killing effect of modern weapons has the characteristics of high speed, high efficiency, high intensity and soft kill (three high and one soft). These characteristics will cause serious injuries, mainly in the form of more serious injuries, multiple injuries and multiple burns. There are many psychological disorders and physiological imbalances, resulting in a high attrition rate, high shock rate and high operation rate (four more and three high), which complicates modern war injuries and brings greater difficulty to rescue
(Hadziahmetovic, 1995;
Klausner and Rozin, 1995). Among all kinds of war wounds, firearm injuries caused by high-speed and small-mass weapons are the highest proportion of war wounds in modern local wars. The wound is complicated and the infection is serious
(Patzkowski et al., 2012; Yee et al., 2017). In research on the injury of important organs, it was found that after the maxillofacial injury of high-speed steel balls, the heart, lungs and other important organs of animals exhibited small-scale flaky bleeding spots. This is the pathological basis for the occurrence and development of serious complications, such as acute respiratory distress syndrome, disseminated intravascular coagulation and multiple organ failure
(Del Sorbo and Slutsky, 2011;
Huang et al., 2013; Lee et al., 2011; Lyons, 2010). This series of complications leads to posttraumatic syndrome and is an important reason for the high mortality rate of troops. Rapid and effective control and treatment of posttraumatic syndrome is a hot research topic at home and abroad. Therefore, it is of great military and scientific significance to establish a reproducible animal model for war-traumatic infection, systemic inflammatory response syndrome, shock and multiple organ failure and a new treatment method based on the animal model. The use of the tree shrew to establish a systemic inflammatory response syndrome model has the following advantages: the tree shrew is a nonhuman primate surrogate animal with abundant resources, low cost and a relatively close relationship with humans. In recent years, it has received increasing attention and the systemic inflammatory response syndrome model of tree shrews is rarely reported at home or abroad.
We established a tree shrew systemic inflammatory response syndrome model and treated it with umbilical cord mesenchymal stem cells. Previous studies have shown that the model was successfully established and that the treatment effect was obvious. In this paper, had control, treatment and model groups. RNA sequencing analysis of the specimens showed that some genes had statistically significantly altered expression. The two most significantly altered genes were ENSTBEG00000013408 (gene name TMEM211) and ENSTBEG00000006837 (gene name C1QL3), which had elevated expression in the model group. The decreased expression of these genes after treatment represents the change in inflammatory factors, indicating that the model group has a significant inflammatory response. Furthermore, the treatment of umbilical cord mesenchymal stem cells has the effect of reducing inflammatory factors, which further proves the anti-inflammatory response of umbilical cord mesenchymal stem cells. Another gene with obvious changes in expression was ENSTBEG00000021330 (gene name ATP8), which was downregulated in the model group (Fold change=0.360939) and upregulated after treatment (Fold change=4.476301), indicating that ATP8 is a gene that contributes to the recovery of systemic inflammatory response syndrome. In the future, we may use this gene to treat systemic inflammatory response syndrome.